Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease

Abstract

AbstractTo date, the treatable traits (TTs) approach has been applied in the context of managing diagnosed diseases. TTs are clinical characteristics and risk factors that can be identified clinically and/or biologically, and that merit treatment if present. There has been an exponential increase in the uptake of this approach by both researchers and clinicians. Realizing the potential of the TTs approach to pre‐clinical disease, this expert review proposes that it is timely to consider acting on TTs present before a clinical diagnosis is made, which might help to prevent development of the full disease. Such an approach is ideal for diseases where there is a long pre‐clinical phase, such as in chronic obstructive pulmonary disease (COPD). The term ‘pre‐COPD’ has been recently proposed to identify patients with respiratory symptoms and/or structural or functional abnormalities without airflow limitation. They may eventually develop airflow limitation with time but patients with pre‐COPD are likely to have traits that are already treatable. This review first outlines the contribution of recently generated knowledge into lifetime lung function trajectories and the conceptual framework of ‘GETomics’ to the field of pre‐COPD. GETomics is a dynamic and cumulative model of interactions between genes and the environment throughout the lifetime that integrates information from multi‐omics to understand aetiology and mechanisms of diseases. This review then discusses the current evidence on potential TTs in pre‐COPD patients and makes recommendations for practice and future research. At a broader level, this review proposes that introducing the TTs in pre‐COPD may help reenergize the preventive approaches to health and diseases.image